proxyvotesnow.com

Home › Companies › Tango Therapeutics, Inc. › 2024-2025

Tango Therapeutics, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings. Page generated 02 October 2026.

  • 7Reported items
  • 128Asset managers
  • 839Fund votes
  • 2025-06-05Meeting date

Proxy season: 2024-2025 2025-2026

Explore Tango Therapeutics, Inc. in the interactive database Compare manager voting policies

How asset managers voted at the Tango Therapeutics, Inc. 2024-2025 meeting

Each item below shows how the 128 asset managers that disclosed a Tango Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Tango Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Combines 7 wordings of this item as funds reported it.

87% fund support · no official result

FOR 87%13%

The 123 asset managers below cast 87% of the shares they voted on this item FOR (62,384,956 for, 9,658,128 against).

FOR: 62,384,956 (86.6%)AGAINST: 9,658,128 (13.4%)
Largest asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
TRV GP IV, LLC16,859,0750 00For
TCG Crossover Management, LLC10,736,0000 00For
T. Rowe Price4,896,0990 00For
GILEAD SCIENCES, INC.4,854,4430 00For
Vanguard3,892,7810 00For
BlackRock3,823,004349 00For
FARALLON CAPITAL MANAGEMENT LLC03,812,392 00Against
Nantahala Capital Management, LLC2,747,0970 00For
Siren, L.L.C.2,245,7610 00For
MARSHALL WACE, LLP01,496,029 00Against
BESSEMER TRUST Co NATIONAL ASSOCIATION1,416,7680 00For
GEODE CAPITAL MANAGEMENT, LLC1,370,7110 00For
Fidelity1,213,1300 00For
Charles Schwab01,097,304 00Against
State Street993,1020 00For
BALYASNY ASSET MANAGEMENT L.P.0879,088 00Against
ArrowMark Colorado Holdings LLC0708,385 00Against
BESSEMER TRUST CO708,3840 00For
BESSEMER TRUST Co OF FLORIDA708,3840 00For
Bessemer Trust CO of Delaware, N.A.708,3840 00For
Bessemer Trust Co of Nevada, National Association708,3840 00For
Samsara BioCapital, LLC630,0000 00For
ORBIMED ADVISORS LLC0550,000 00Against
Woodline Partners LP441,9040 00For
JACOBS LEVY EQUITY MANAGEMENT, INC387,1350 00For

Showing the 25 largest of 123 asset managers. See all 123 in the interactive database.

2. NON-BINDING, ADVISORY VOTE ON THE FREQUENCY OF FUTURE NON-BINDING, ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Combines 7 wordings of this item as funds reported it.

99.9% fund support · no official result

11%ONE YEAR 55%1 YEAR 33%

The 121 asset managers below cast 99.9% of the shares they voted on this item FOR (5,979,665 for, 284 against).

FOR: 5,979,665 (11.0%)AGAINST: 284 (0.0%)ONE YEAR: 29,941,863 (55.2%)1 YEAR: 17,963,256 (33.1%)THREE YEARS: 381,430 (0.7%)3 YEARS: 13,229 (0.0%)1-YEAR: 2,399 (0.0%)SHARES YEAR 1: 2,000 (0.0%)
Largest asset managers voting on “NON-BINDING, ADVISORY VOTE ON THE FREQUENCY OF FUTURE NON-BINDING, ADVISORY VOTES ON THE COMPENSATION OF OUR N” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
EcoR1 Capital, LLC00 00One Year
T. Rowe Price00 00One Year
GILEAD SCIENCES, INC.00 001 Year
Vanguard00 00One Year
BlackRock00 001 Year
FARALLON CAPITAL MANAGEMENT LLC3,812,3920 00For
Siren, L.L.C.00 001 Year
Blue Owl Capital Holdings LP2,146,6520 00For
MARSHALL WACE, LLP00 001 Year
BESSEMER TRUST Co NATIONAL ASSOCIATION00 00One Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
Fidelity00 00One Year
Charles Schwab00 001 Year
State Street00 00One Year
BALYASNY ASSET MANAGEMENT L.P.00 001 Year
ArrowMark Colorado Holdings LLC00 001 Year
BESSEMER TRUST CO00 00One Year
BESSEMER TRUST Co OF FLORIDA00 00One Year
Bessemer Trust CO of Delaware, N.A.00 00One Year
Bessemer Trust Co of Nevada, National Association00 00One Year
Samsara BioCapital, LLC00 001 Year
ORBIMED ADVISORS LLC00 001 Year
Woodline Partners LP00 00One Year
JACOBS LEVY EQUITY MANAGEMENT, INC00 001 Year
Dimensional00 00Three Years

Showing the 25 largest of 121 asset managers. See all 121 in the interactive database.

3. ELECTION OF CLASS I DIRECTOR: LESLEY ANN CALHOUN

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 90%10%

The 42 asset managers below cast 100% of the shares they voted on this item FOR (9,821,019 for, 0 against).

FOR: 9,821,019 (90.3%)ABSTAIN: 1,052,864 (9.7%)
Largest asset managers voting on “ELECTION OF CLASS I DIRECTOR: LESLEY ANN CALHOUN” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,810,5900 00For
BlackRock2,103,4720 00For
T. Rowe Price1,631,1130 00For
Fidelity1,210,3940 00For
Charles Schwab548,6520 00For
Dimensional00 290,9420Abstain
Jackson National173,3200 13,2290For
Equitable88,7650 64,9400For
TIAA141,5970 00For
SEI00 131,1300Abstain
BRIDGEWAY FUNDS INC00 125,0000Abstain
ETF Series Solutions00 65,3270Abstain
American Century00 65,1520Abstain
Putnam62,5750 00For
Invesco00 44,5980Abstain
Lincoln Financial00 38,0000Abstain
ETFis Series Trust I00 35,8260Abstain
Global X00 28,3230Abstain
Northern Trust00 27,6210Abstain
AIG/SunAmerica00 23,3730Abstain
John Hancock00 19,3400Abstain
Pacific Life15,8910 00For
ProShares00 14,7220Abstain
Voya00 14,3980Abstain
Nationwide12,2610 00For

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

4. TO APPROVE AN AMENDMENT TO OUR SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 200,000,000 TO 400,000,000.

CAPITAL STRUCTURE

99.9% fund support · no official result

FOR 99.9%

The 42 asset managers below cast 99.9% of the shares they voted on this item FOR (10,873,583 for, 300 against).

FOR: 10,873,583 (100.0%)AGAINST: 300 (0.0%)
Largest asset managers voting on “TO APPROVE AN AMENDMENT TO OUR SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,810,5900 00For
BlackRock2,103,4720 00For
T. Rowe Price1,631,1130 00For
Fidelity1,210,3940 00For
Charles Schwab548,6520 00For
Dimensional290,9420 00For
Jackson National186,5490 00For
Equitable153,7050 00For
TIAA141,5970 00For
SEI131,1300 00For
BRIDGEWAY FUNDS INC125,0000 00For
ETF Series Solutions65,3270 00For
American Century65,1520 00For
Putnam62,5750 00For
Invesco44,5980 00For
Lincoln Financial38,0000 00For
ETFis Series Trust I35,8260 00For
Global X28,3230 00For
Northern Trust27,6210 00For
AIG/SunAmerica23,3730 00For
John Hancock19,3400 00For
Pacific Life15,8910 00For
ProShares14,7220 00For
Voya14,3980 00For
Nationwide12,2610 00For

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

5. To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 42 asset managers below cast 99.9% of the shares they voted on this item FOR (10,873,583 for, 300 against).

FOR: 10,873,583 (100.0%)AGAINST: 300 (0.0%)
Largest asset managers voting on “To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,810,5900 00For
BlackRock2,103,4720 00For
T. Rowe Price1,631,1130 00For
Fidelity1,210,3940 00For
Charles Schwab548,6520 00For
Dimensional290,9420 00For
Jackson National186,5490 00For
Equitable153,7050 00For
TIAA141,5970 00For
SEI131,1300 00For
BRIDGEWAY FUNDS INC125,0000 00For
ETF Series Solutions65,3270 00For
American Century65,1520 00For
Putnam62,5750 00For
Invesco44,5980 00For
Lincoln Financial38,0000 00For
ETFis Series Trust I35,8260 00For
Global X28,3230 00For
Northern Trust27,6210 00For
AIG/SunAmerica23,3730 00For
John Hancock19,3400 00For
Pacific Life15,8910 00For
ProShares14,7220 00For
Voya14,3980 00For
Nationwide12,2610 00For

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

6. To vote on a non-binding, advisory basis, on the frequency of future non-binding, advisory votes on executive compensation

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (27,789,249 for, 0 against).

FOR: 27,789,249 (100.0%)
Largest asset managers voting on “To vote on a non-binding, advisory basis, on the frequency of future non-binding, advisory votes on executive ” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
TRV GP IV, LLC16,859,0750 00For
TCG Crossover Management, LLC10,736,0000 00For
TRV GP VI, LLC194,1740 00For

7. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

0% fund support · no official result

AGAINST 100%

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 67,742 against).

AGAINST: 67,742 (100.0%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
ALGERT GLOBAL LLC045,180 00Against
JPMorgan022,562 00Against

Largest Tango Therapeutics, Inc. shareholders voting in 2024-2025

Ranked by the number of Tango Therapeutics, Inc. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 108,107,890 shares outstanding at the time of that meeting.

Top Tango Therapeutics, Inc. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1TRV GP IV, LLC 15.59%
2TCG Crossover Management, LLC 9.93%
3T. Rowe Price 4.53%
4GILEAD SCIENCES, INC. 4.49%
5Vanguard 3.60%
6BlackRock 3.54%
7FARALLON CAPITAL MANAGEMENT LLC 3.53%
8Nantahala Capital Management, LLC 2.54%
9Siren, L.L.C. 2.08%
10MARSHALL WACE, LLP 1.38%

Reported Tango Therapeutics, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Tango Therapeutics, Inc. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
RTW Investments, LP 12.30% 13G
Adage Capital Management, L.P. 11.85% 13G
TCG Crossover GP II, LLC 10.73% 13G
Farallon Partners, L.L.C. 10.14% 13G
Entities affiliated with Boxer Capital, LLC 9.90% DEF14A
EcoR1 Capital, LLC 9.82% DEF14A
TCG Crossover II 9.71% DEF14A
FMR LLC 9.16% 13G
Woodline Partners LP 7.40% 13G
Nextech Crossover I GP S.a. r.l. 6.72% 13G

Percentages above are of 108,107,890 shares outstanding, as reported by Tango Therapeutics, Inc. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Tango Therapeutics, Inc.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Tango Therapeutics, Inc.'s shareholder meeting held 2025-06-05, in the 2024-2025 proxy season, 128 asset managers reported how they voted in their SEC Form N-PX filings, covering 839 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — the reporting funds cast 87% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Tango Therapeutics, Inc. proxy season coverage: 2024-2025 (this page) · 2025-2026.